Hunter Immunology Limited Company Profile

18:05 EDT 18th March 2019 | BioPortfolio

Our lead product is a vaccine currently called HI-164OV. It works by controlling bacterial colonisation of airways damaged by inhaled toxins.

It has been developed to treat patients with Chronic Obstructive Pulmonary Disease (COPD) which includes bronchitis and emphysema.

HI-164OV could help improve the lives of over one million Australians with COPD, and contribute towards saving Australia more than $300m in healthcare costs.

The global incidence of airways diseases like COPD is growing rapidly in direct proportion to the rise in airborne pollutants and smoking in the developing world.

The results of a major Phase IIb clinical study of the vaccine carried out at 21 Australian hospitals are due to be released mid year 2012.


Suite 100
4 Bridge Street
NSW 2000


Phone: +61 (0) 407-218-922

News Articles [249 Associated News Articles listed on BioPortfolio]

Lewis Katz School of Medicine at Temple University, Hunter College awarded $13.5 million NCI/NIH Grant

(Temple University Health System) The Lewis Katz School of Medicine at Temple University (LKSOM) and Hunter College of the City University of New York (Hunter) have jointly received a five-year, $13.5...

A shared past for East Africa's hunter-gatherers

(University of Pennsylvania) Research led by University of Pennsylvania scientists offers a new look at African genetic diversity, with data from 50 populations. Among other insights, their analysis s...

Short stature in rainforest hunter-gatherers potentially linked to cardiac adaptations

(Penn State) African and Asian rainforest hunter-gatherers share short stature, and now an international team of researchers has shown that this is an example of convergent adaptation that may also be...

TRIANNI & the German Society for Immunology (DGfI) honors outstanding young scientists.

Every year, the German Society for Immunology awards two doctoral and three early-career prizes to young scientists who have made an outstanding contribution in the field of immunology. The award cere...

GE Healthcare and Parker Domnick Hunter Announce Distribution And Collaboration Agreements In Biopharmaceutical Purification

GE Healthcare and Parker domnick hunter, a division of Parker Hannifin announced that they have entered into an exclusive agreement for the supply and distribution of products for biopharmaceutical pu...

Furukawa Electric Launches Single Cell Hunter for Functional Identification and Recovery of Live Single Cells

Microchip-based high-throughput screening system helps open innovation and creativity in life sciences. Furukawa Electric (TOKYO:5801)(ISIN:JP3827200001) announced the launch ...

Global Immunology Partnering 2012-2018: Deal trends, players and financials

LONDON, Oct. 2, 2018 /PRNewswire/ -- Global Immunology Partnering 2012 to 2018 provides the full collection of Immunology disease deals signed between the world's pharmaceutical Read more...

Hemispherx Biopharma Announces First Large Ampligen Shipment to a Clinical Site

Hemispherx Biopharma (NYSE:HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, shipped 720 vials of Ampligen to the Myalgic Encephalomye...

Drugs and Medications [35 Associated Drugs and Medications listed on BioPortfolio]

Adenosine [wockhardt limited]


Felodipine [wockhardt limited]

Felodipine Extended-Release Tablets, USP Rx only

Ranitidine [wockhardt limited]

Ranitidine Syrup (Ranitidine Oral Solution, USP)

Risperidone [wockhardt limited]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Amlodipine besylate [wockhardt limited]

These highlights do not include all the information needed to use amlodipine besylate tablets safely and effectively. See full prescribing information for amlodipine besylate tablets. Amlodipine Besyl...

PubMed Articles [725 Associated PubMed Articles listed on BioPortfolio]

A genomic Neolithic time transect of hunter-farmer admixture in central Poland.

Ancient DNA genome-wide analyses of Neolithic individuals from central and southern Europe indicate an overall population turnover pattern in which migrating farmers from Anatolia and the Near East la...

Human Cooperation: The Hunter-Gatherer Puzzle.

In tracing the roots of human cooperation, researchers have gleaned insights from the sociality of contemporary hunter-gatherers. A new study among the Hadza, one of the few surviving foraging populat...

A comparison of the Nix Colour Sensor Pro™ and HunterLab MiniScan™ colorimetric instruments when assessing aged beef colour stability over 72 h display.

We compared the capacity for the Nix Colour Sensor Pro™ (NIX) and HunterLab MiniScan™ (HUNTER) to detect colour variation using aged (0, 3 and 5 weeks) and then displayed (0, 1, 2 and 3 d) bee...

Bow Hunter's syndrome caused by compression of the subaxial vertebral artery - surgical technique of antero-lateral decompression (video).

Bow hunter's syndrome (BHS) is a rare clinical condition. It is caused by dynamic com-pression of the vertebral artery either at the level of the transverse foramina (V2 segment) or at the atlanto-axi...

The demographic and adaptive history of central African hunter-gatherers and farmers.

Central Africa, a forested region that supports an exceptionally high biodiversity, hosts the world's largest group of hunter-gatherers, who live in close proximity with groups that have adopted agric...

Clinical Trials [114 Associated Clinical Trials listed on BioPortfolio]

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Study HGT-HIT-094 is a multicenter study designed to determine the effect on clinical parameters of neurodevelopmental status of monthly IT administration of idursulfase-IT 10 mg for 12 mo...

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

This long-term study will provide Elaprase treatment to children enrolled in this study and will utilize data from both enrolled patients and Hunter Outcome Survey (HOS) patient registry d...

Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)

The purpose of this non-interventional, observational study which is conducted in Mexico is to evaluate the safety profile of elaprase (idulsurfase) in participants with hunter syndrome (m...

An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients

The objective of this study is to evaluate the effect of anti-idursulfase IgG, IgM & IgE antibodies on idursulfase safety (measured by infusion related adverse events) between patients who...

Pilot Prospective Study of Two Methods of Revascularization of the Femoral Artery (SFA): Stenting in the SFA, and Stenting of the SFA, Supplemented by Fasciotomy in Hunter Channel.

Comparison of two methods for revascularization of the superficial femoral artery: stenting of the superficial femoral artery vs. stenting of the superficial femoral artery supplemented wi...

Companies [328 Associated Companies listed on BioPortfolio]

Hunter Immunology Limited

Our lead product is a vaccine currently called HI-164OV. It works by controlling bacterial colonisation of airways damaged by inhaled toxins. It has been developed to treat patients with Chronic O...

Hunter Medical Inc.

Hunter Medical, Inc. was founded in 2013 by Lee Hunter M.D., M.B.A., a board-certified orthopaedic surgeon who specializes in surgery of the upper extremity, particularly the elbo...

Global Hunter Securities

Global Hunter Securities, LLC is a full service investment bank focusing on middle market corporate and institutional clients around the world. The firm provides insightful resear...


Bioxyne Limited (ASX:BXN) is an Australian immunotherapeutics business created in April 2012 through the reverse takeover of Probiomics (ASX: PCC) by privately held Hunter Immunology. The Company&rs...

Hunter-Fleming Ltd

Hunter-Fleming is an innovative pharmaceutical development company, specializing in the development of radically novel therapeutics relevant to the treatment of acute and chronic inflammatory degenera...

More Information about "Hunter Immunology Limited" on BioPortfolio

We have published hundreds of Hunter Immunology Limited news stories on BioPortfolio along with dozens of Hunter Immunology Limited Clinical Trials and PubMed Articles about Hunter Immunology Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hunter Immunology Limited Companies in our database. You can also find out about relevant Hunter Immunology Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Corporate Database Quicklinks

Searches Linking to this Company Record